Larry Weathers
Cardiovascular Disease · Rogers, ARNPI 1770635047
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 398 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 10.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,965 and has fallen 97.7% since, to $46 in 2024.
Across 398 payments — averaging $15.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amarin Pharma, Inc.$627
- Novartis$585
- Johnson & Johnson$580
- Abbott$540
- Amgen$533
- AstraZeneca$490
- plus $3K from 23 others
What the payments were for
- Food & beverage$6,01499%
- Education$691%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amarin Pharma, Inc. | 31 | $627 |
| Novartis | 37 | $585 |
| Johnson & Johnson | 80 | $580 |
| Abbott | 24 | $540 |
| Amgen | 41 | $533 |
| AstraZeneca | 21 | $490 |
| Boehringer Ingelheim | 34 | $462 |
| Pfizer | 44 | $448 |
| Heartflow, Inc. | 6 | $444 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 15 | $208 |
| Edwards Lifesciences | 1 | $182 |
| Merck | 11 | $164 |
| Regeneron Healthcare Solutions, Inc. | 9 | $119 |
| Kiniksa Pharmaceuticals, Ltd. | 6 | $107 |
| Sanofi-aventis U.S. LLC | 6 | $90 |
| Bayer | 4 | $62 |
| Esperion Therapeutics, Inc. | 5 | $60 |
| E.r. Squibb & Sons, L.L.C. | 4 | $55 |
| Chiesi USA, Inc. | 4 | $47 |
| Alnylam Pharmaceuticals Inc. | 2 | $45 |
| Baxter Healthcare | 2 | $41 |
| Kowa Pharmaceuticals America, Inc. | 3 | $34 |
| Davol Inc. | 1 | $33 |
| Atricure, Inc. | 1 | $31 |
| Livanova USA, Inc. | 1 | $24 |
| Gilead | 2 | $23 |
| Philips North America LLC | 1 | $22 |
| Bardy Diagnostics, Inc. | 1 | $15 |
| GSK | 1 | $12 |
How this compares
$6,084 in reported general payments places this provider in the 65th percentile of 130 cardiovascular disease providers in Arkansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 33 | $37,300 |
| XareltoRivaroxaban | 16 | $17,506 |
| Atorvastatin Calcium | 69 | $652 |
| Chlorthalidone | 21 | $482 |
| Metoprolol Succinate | 20 | $289 |
| ClopidogrelClopidogrel Bisulfate | 33 | $201 |
| Amlodipine Besylate | 30 | $159 |
| Carvedilol | 18 | $120 |
| Metoprolol Tartrate | 11 | $107 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 11 | $94 |
| Warfarin Sodium | 19 | $92 |
| Losartan Potassium | 16 | $80 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 14 | $74 |
| Rosuvastatin Calcium | 11 | $64 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $448 | $37,30033 claims |
| Johnson & JohnsonXarelto | $580 | $17,50616 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 130 cardiovascular disease providers in Arkansas.
Other cardiovascular disease in Rogers
- Amr El-ShafeiRogers$23K
- Kiran KurichetyRogers$9K
- Philip RileyRogers$8K
- Lance WeathersRogers$8K
- Robert StuppyRogers$5K
- Ian CawichLittle Rock$294K
- Barry TedderJonesboro$130K
- Harvinder DodEl Dorado$126K
- William RollefsonLittle Rock$74K
- Andre PaixaoLittle Rock$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.